These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 37282618)

  • 1. EEG changes as an indication of central nervous system involvement following cyclopentolate 1% eye drops; a randomized placebo-controlled pilot study in a pediatric population.
    van Minderhout HM; Joosse MV; Klaassen ES; Schalij-Delfos NE
    Strabismus; 2023 Jun; 31(2):82-96. PubMed ID: 37282618
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adverse reactions following routine anticholinergic eye drops in a paediatric population: an observational cohort study.
    van Minderhout HM; Joosse MV; Grootendorst DC; Schalij-Delfos NE
    BMJ Open; 2015 Dec; 5(12):e008798. PubMed ID: 26700273
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adverse reactions to 1% cyclopentolate eye drops in children: an analysis using logistic regression models.
    Imai T; Hasebe S; Furuse T; Morisawa S; Hasebe K; Nagata Y; Tokutake T; Moriyama Y
    Ophthalmic Physiol Opt; 2021 Mar; 41(2):424-430. PubMed ID: 33300632
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A randomized clinical trial using atropine, cyclopentolate, and tropicamide to compare refractive outcome in hypermetropic children with a dark iris; skin pigmentation and crying as significant factors for hypermetropic outcome.
    van Minderhout HM; Joosse MV; Grootendorst DC; Schalij-Delfos NE
    Strabismus; 2019 Sep; 27(3):127-138. PubMed ID: 31234691
    [No Abstract]   [Full Text] [Related]  

  • 5. [Influence of the instillation of two versus three eyedrops of cyclopentolate 0.5% on refraction of Caucasian nonstrabismic children].
    Gadioux-Madern F; Lelez ML; Sellami L; Santallier M; Fourquet F; Pisella PJ; Arsene S
    J Fr Ophtalmol; 2008 Jan; 31(1):51-5. PubMed ID: 18401299
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Clinical Randomized Trial Comparing the Cycloplegic Effect of Cyclopentolate Drops Applied to Closed Eyelids Versus Open Eyelids.
    Zurevinsky J; Sawchuk K; Lim HJ; Lee CH; Rubab S
    Am Orthopt J; 2016 Jan; 66(1):114-121. PubMed ID: 27799585
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epileptic seizures induced by cycloplegic eye drops.
    Wygnanski-Jaffe T; Nucci P; Goldchmit M; Mezer E
    Cutan Ocul Toxicol; 2014 Jun; 33(2):103-8. PubMed ID: 23815170
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incidence of side effects of topical atropine sulfate and cyclopentolate hydrochloride for cycloplegia in Japanese children: a multicenter study.
    Wakayama A; Nishina S; Miki A; Utsumi T; Sugasawa J; Hayashi T; Sato M; Kimura A; Fujikado T
    Jpn J Ophthalmol; 2018 Sep; 62(5):531-536. PubMed ID: 30046935
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cycloplegic Refraction in Hyperopic Children: Effectiveness of a 0.5% Tropicamide and 0.5% Phenylephrine Addition to 1% Cyclopentolate Regimen.
    Yoo SG; Cho MJ; Kim US; Baek SH
    Korean J Ophthalmol; 2017 Jun; 31(3):249-256. PubMed ID: 28471102
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Short-term effects of cyclopentolate and tropicamide eye drops on macular choroidal thickness in myopic children.
    Kobia-Acquah E; Flitcroft DI; Lingham G; Kerin E; Loughman J
    Ophthalmic Physiol Opt; 2024 Mar; 44(2):280-291. PubMed ID: 38037443
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Retinoscopy in infants using a near noncycloplegic technique, cycloplegia with tropicamide 1%, and cycloplegia with cyclopentolate 1%.
    Twelker JD; Mutti DO
    Optom Vis Sci; 2001 Apr; 78(4):215-22. PubMed ID: 11349929
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Optimal dosage of cyclopentolate 1% for complete cycloplegia: a randomized clinical trial.
    Bagheri A; Givrad S; Yazdani S; Reza Mohebbi M
    Eur J Ophthalmol; 2007; 17(3):294-300. PubMed ID: 17534806
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Comparative study of cyclopentolate drops versus spray in cycloplegia in children].
    Chafai A; Ajdnik S; Lejeune L; Cordonnier M
    J Fr Ophtalmol; 2006 Oct; 29(8):896-9. PubMed ID: 17075505
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cost-effectiveness of cycloplegic agents: results of a randomized controlled trial in nigerian children.
    Ebri A; Kuper H; Wedner S
    Invest Ophthalmol Vis Sci; 2007 Mar; 48(3):1025-31. PubMed ID: 17325142
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A randomized clinical trial using cyclopentolate and tropicamide to compare cycloplegic refraction in Chinese young adults with dark irises.
    Pei R; Liu Z; Rong H; Zhao L; Du B; Jin N; Zhang H; Wang B; Pang Y; Wei R
    BMC Ophthalmol; 2021 Jun; 21(1):256. PubMed ID: 34112149
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cyclopentolate eye drops-induced anaphylaxis in an infant.
    Terece SP; Ertoy-Karagöl Hİ; Köken G; Atalay HT; Türkcan BT; Vural Ö; Bakırtaş A
    Turk J Pediatr; 2022; 64(5):915-918. PubMed ID: 36305442
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The cycloplegic effects of cyclopentolate and tropicamide on myopic children.
    Lin LL; Shih YF; Hsiao CH; Su TC; Chen CJ; Hung PT
    J Ocul Pharmacol Ther; 1998 Aug; 14(4):331-5. PubMed ID: 9715436
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of a Cycloplegic Agent Administered as a Spray in the Pediatric Population.
    Vagge A; Del Noce C; Pellegrini M; Cappelli F; Musolino M; Bernabei F; Giannaccare G; Traverso CE
    J Pediatr Ophthalmol Strabismus; 2020 Sep; 57(5):301-304. PubMed ID: 32956479
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Eye colour and skin pigmentation as significant factors for refractive outcome and residual accommodation in hypermetropic children: a randomized clinical trial using cyclopentolate 1% and tropicamide 1.
    van Minderhout HM; Joosse MV; Grootendorst DC; Schalij-Delfos NE
    Acta Ophthalmol; 2022 Jun; 100(4):454-461. PubMed ID: 34672100
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A cross-over study of the cycloplegic effects of a single topical application of cyclopentolate-phenylephrine and routine atropinization for 3.5 days.
    Zetterström C
    Acta Ophthalmol (Copenh); 1985 Oct; 63(5):525-9. PubMed ID: 3907259
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.